Your session is about to expire
← Back to Search
Animal Assisted Therapy for Traumatic Brain Injury
N/A
Recruiting
Research Sponsored by Children's Hospital Medical Center, Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosis: Participants must be admitted to the inpatient rehabilitation unit for treatment of an acquired brain injury (TBI, brain tumor, infection, etc.)
Age at the time of screening: 4-21 years old
Must not have
Disease: Participant is on contact precautions or has a communicable disease that may pose a risk to the dog or dog handler or has a compromised immune system where interacting with the dog and/or handler would be of significant risk to the patient.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up throughout study completion - an average of 2 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial tests whether having dogs in therapy sessions helps children with brain injuries stay engaged in their rehabilitation. The goal is to see if this approach makes therapy more effective and enjoyable for these children.
Who is the study for?
This trial is for children and adolescents aged 4-21 who are in inpatient rehab after a brain injury like TBI or infection. They must be responsive (Rancho score >2), have consent from guardians, and assent to participate. It's not for those with communicable diseases, immune issues, dog allergies/fears, history of animal abuse, or developmental delays before the injury.
What is being tested?
The study tests if including dogs in physical and occupational therapy sessions improves engagement during rehabilitation for pediatric brain injuries. It uses a crossover design where each patient experiences both standard care and animal-assisted therapy to see which works better.
What are the potential side effects?
Since this trial involves animal-assisted therapy rather than medication, traditional side effects aren't expected. However, there might be risks related to interactions with animals such as stress or discomfort if the child has underlying fears or allergies.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am admitted for rehab due to a brain injury like TBI, tumor, or infection.
Select...
I am between 4 and 21 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am not on contact precautions, do not have a communicable disease, and my immune system is not compromised.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ throughout study completion - an average of 2 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~throughout study completion - an average of 2 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Objective Engagement rating.
Patient Participation/engagement
Secondary study objectives
Automated mood assessment
Objective mood assessment
Patient-reported mood
+2 moreOther study objectives
Anthropomorphism
Patient-animal rapport
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
animal assisted therapy
Group II: ControlActive Control1 Intervention
Treatment as usual
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for Traumatic Brain Injury (TBI) often include therapies that enhance patient engagement through emotional and psychological support, such as Animal-Assisted Therapy. These therapies work by providing emotional comfort, reducing anxiety, and improving mood, which can significantly enhance a patient's willingness to participate in and adhere to rehabilitative exercises.
This increased engagement is crucial for effective rehabilitation, as it can lead to more consistent practice of physical and occupational therapies, ultimately improving functional outcomes and quality of life for TBI patients.
Guidelines for head injury: their use and limitations.
Guidelines for head injury: their use and limitations.
Find a Location
Who is running the clinical trial?
Children's Hospital Medical Center, CincinnatiLead Sponsor
839 Previous Clinical Trials
6,565,513 Total Patients Enrolled
Miami UniversityOTHER
14 Previous Clinical Trials
2,830 Total Patients Enrolled
Ohio State UniversityOTHER
871 Previous Clinical Trials
655,881 Total Patients Enrolled
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
2,067 Previous Clinical Trials
2,747,354 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are very scared of dogs.I am admitted for rehab due to a brain injury like TBI, tumor, or infection.You have a history of delayed development before your brain injury.I am between 4 and 21 years old.I am not on contact precautions, do not have a communicable disease, and my immune system is not compromised.You have a strong allergy to dogs.You have a Rancho score higher than 2 when you join the study (as seen in your medical records).I am either male or female.You have a Rancho score of 2 or lower.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.